Search research articles
Contact Us
Filters
Showing results (1-10 of 80) with videos related to
Page
of 8
Sort By:
ACS Pharmacology & Translational Science
|
December 21, 2020
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810
Najam A Sharif
Biofactors (Oxford, England)
|
May 20, 2022
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects
Najam A Sharif
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 20, 2015
Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axes
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 12, 2018
iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 20, 2022
Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction
Najam A Sharif
Frontiers in Pharmacology
|
October 4, 2021
Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Najam A Sharif
Experimental Eye Research
|
March 23, 2023
Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness
Najam A Sharif
Molecular Aspects of Medicine
|
November 17, 2023
Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
Najam A Sharif
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
Najam A Sharif
Page
of 8
Search research articles
Search
Showing results (1-10 of 80) with videos related to
Sort By:
Page
of 8
ACS Pharmacology & Translational Science
|
December 21, 2020
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810
Najam A Sharif
Biofactors (Oxford, England)
|
May 20, 2022
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects
Najam A Sharif
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 20, 2015
Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axes
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 12, 2018
iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants
Najam A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 20, 2022
Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction
Najam A Sharif
Frontiers in Pharmacology
|
October 4, 2021
Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Najam A Sharif
Experimental Eye Research
|
March 23, 2023
Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness
Najam A Sharif
Molecular Aspects of Medicine
|
November 17, 2023
Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
Najam A Sharif
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
Najam A Sharif
Page
of 8